Clinicopathological and immunohistochemical analysis of twenty-five head and neck osteosarcomas

Oral Oncology

Volumn 39, Issue 5, 2003, Pages 521-530

  Takahama Jr , Ademar ^a   De Abreu Alves, Fábio ^a   Lopes Pinto, Clóvis Antonio ^b   Lopes Carvalho, André ^b   Kowalski, Luiz Paulo ^b   Lopes, Márcio Ajudarte ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Head and neck; Immunohistochemistry; Osteosarcoma; Prognostic factors; Survival analysis

Indexed keywords

CISPLATIN; CYCLIN DEPENDENT KINASE 4; DOXORUBICIN; IFOSFAMIDE; KI 67 ANTIGEN; ONCOPROTEIN; PROTEIN MDM2; PROTEIN P53; PROTEIN PCNA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHONDROSARCOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MANDIBLE CANCER; METASTASIS; OSTEOBLAST; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCHOOL CHILD; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0037716934     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(03)00017-4     Document Type: Article

References (56)

1. Huvos A.G. Bone tumours: diagnosis, treatment, and prognosis. 2nd ed. 1991;WB Saunders, Philadelphia. p. 88-156.
2. Vege D.S., Borges A.M., Aggrawal K., Balasubramaniam G., Parikh D.M., Bhaser B. Osteosarcoma of the craniofacial bones. A clinico-pathological study. J Craniomaxillofac Surg. 19(2):1991;90-93.
3. Wanebo H.J., Koness R.J., MacFarlane J.K.et al. Head and neck sarcoma: report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research. Head Neck. 14(1):1992;1-7.
4. Mark R.J., Sercarz J.Á., Tran L., Dodd L.G., Selch M., Calcaterra T.C. Osteosarcoma of the head and neck. The UCLA experience. Arch Otolaryngol Head Neck Surg. 117(7):1991;761-766.
5. Delgado R., Maafs E., Alfeiran A.et al. Osteosarcoma of the jaw. Head Neck. 16(3):1994;246-252.
6. Dickens P., Wei W.I., Sham J.S. Osteosarcoma of the maxilla in Hong Kong. Chinese postirradiation for nasopharyngeal carcinoma. Cancer. 66(9):1990;1924-1926.
7. Garrington G.E., Scofield H.H., Cornyn J. Osteosarcoma of the jaws. analysis of 56 cases Cancer. 20(3):1967;377-391.
8. Kassir R.R., Rassekh C.H., Kinsella J.B., Segas J., Carrau R.L., Hokanson J.A. Osteosarcoma of the head and neck. meta-analysis of nonrandomized studies Laryngoscope. 107(1):1997;56-61.
9. Chindia M.L. Osteosarcoma of the jaw bones. Oral Oncol. 37(7):2001;545-547.
10. Mardinger O., Givol N., Talmi Y., Taicher S. Osteosarcoma of the jaw. The Chaim Sheba Medical Center experience Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 91(4):2001;445-451.
11. Unni K.K., Dahlin D.C. Osteosarcoma. pathology and classification Semin Roentgenol. 24(3):1989;143-152.
12. Russ J.E., Jesse R.H. Management of osteosarcoma of the maxilla and mandible. Am J Surg. 140(4):1980;572-576.
13. Bertoni F., Dallera P., Bacchini P., Marchetti C., Campobassi A. The Institute Rizzoli-Beretta experience with osteosarcoma of the jaw. Cancer. 68(7):1991;1555-1563.
14. Craft A.W. Osteosarcoma and chondrossarcoma. Voute P.A., Barret A., Lemerle J. Cancer in children. Clinical management. 1992;282-294 Springer-Verlag, London.
15. Smeele L.E., Kostense P.J., van der Waal I., Snow G.B. Effect of chemotherapy on survival of craniofacial osteosarcoma. a systematic review of 201 patients J Clin Oncol. 15(1):1997;363-367.
16. Ha P.K., Eisele D.W., Frassica F.J., Zahurak M.L., McCarthy E.F. Osteosarcoma of the head and neck. a review of Johns Hopkins experience Laryngoscope. 109(6):1999;964-969.
17. Goorin A.M., Abelson H.T., Frei E. Osteosarcoma. fifteen years later N Engl J Med. 313(26):1985;1637-1643.
18. Eilber F.R., Rosen G. Adjuvant chemotherapy of osteosarcoma. Semin Oncol. 16(4):1989;312-323.
19. Pratt C.B., Champion J.E., Fleming I.D.et al. Adjuvant chemotherapy for osteosarcoma of the extremity: long term results of two consecutive prospective protocol studies. Cancer. 65(3):1990;439-445.
20. Bramwell V.H. The role of chemotherapy on osteosarcoma. Crit Rev Oncol Hematol. 20(1-2):1995;61-85.
21. Bennett J.H., Thomas G., Evans A.W., Speight P.M. Osteosarcoma of the jaws. a 30-year retrospective review Oral Surg Oral Med Oral Pathol. 90(3):2000;323-333.
22. Cordon-Cardo C. Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol. 147(3):1995;545-560.
23. Hall M., Peters G. Genetics alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer. Adv Cancer Res. 68:1996;67-107.
24. Nigro J.M., Baker S.J., Preisinger A.C.et al. Mutations in the p53 gene occur in diverse human tumour types. Nature. 342(6250):1989;707.
25. Wunder J.S., Eppert K., Burrow S.R., Gogkoz N., Bell R.S., Andrulis I.L. Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas. Oncogene. 18(3):1999;783-788.
26. Gamberi G., Ragazzini P., Benassi M.S.et al. Analysis of 12q13-15 genes in parosteal osteosarcoma. Clin Orthop. 377:2000;195-204.
27. Oliner J.D., Kinzler K.W., Meltzer P.S., George D.L., Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature. 358(6381):1992;80-83.
28. Leach F.S., Tokino T., Meltzer P.et al. p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res. 53(10 Suppl):1993;2231-2234.
29. Matsushime H., Quelle D.E., Shurtleff S.A., Shibuya M., Sherr C.J., Kato J.Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol. 14(3):1994;2066-2076.
30. Zhu Q., Tipoe G.L., White F.H. Proliferative activity as detected by immunostaining with Ki67 and proliferating cell nuclear antigen in benign and malignant epithelial lesions of the human paratid gland. Anal Quant Cytol Histol. 21(4):1999;336-342.
31. Clark J.L., Unni K.K., Dahlin D.C., Devine K.D. Osteosarcoma of the jaw. Cancer. 51(12):1983;2311-2316.
32. August M., Magennis P., Dewitt D. Osteogenic Sarcoma of the jaws. factors influencing prognosis Int J Oral Maxillofac Surg. 26(3):1997;198-204.
33. Doval D.C., Kumar R.V., Kannan V.et al. Osteosarcoma of the jaw bones. Br J Oral Maxillofac Surg. 35(5):1997;357-362.
34. Oda D., Bavisotto L.M., Schmidt R.A.et al. Head and Neck Osteosarcoma at the University of Washington. Head Neck. 19(6):1997;513-523.
35. Van Es R.J., Keus R.B., van der Wall I., Koole R., Vermey A. Osteosarcoma of the jaw bones. Long-term follow up of 48 cases. Int J Oral Maxillofac Surg. 26(3):1997;191-197.
36. Tanzawa H., Uchiyama S., Sato K. Statistical observation of osteosarcoma of the maxillofacial region in Japan. Oral Surg Oral Med Oral Pathol. 72(4):1991;444-448.
37. Lopes M.A., Nikitakis N.G., Ord R.A., Sauk J. Jr. Amplification and protein expression of chromosome 12q13-15 genes in osteosarcomas of the jaws. Oral Oncol. 37(7):2001;566-571.
38. Nachman J., Simon M.A., Dean L., Shermeta D., Dawson P., Vogelzang N.J. Disparate histological responses in simultaneously resected primary and metastatic osteosarcoma following intravenous neoadjuvant chemotherapy. J Clin Oncol. 5(8):1987;1185-1190.
39. Wozniak W., Rychlowska M., Liebhart M., Klepacka T., Poznanska A. Preliminary estimation of prognostic factors in osteosarcoma in children on the basis of treatment results. Med Oncol. 21:1993;596.
40. Levine A.J. The p53 tumour-suppressor gene. N Engl J Med. 326(20):1992;1350-1351.
41. Oliveira P., Nogueira M., Pinto A., Almeida O. Analysis of p53 expression in osteosarcoma of the jaw. correlation with clinicopathologic and DNA ploidy findings Human Pathol. 28(12):1997;1361-1365.
42. Miller C.W., Aslo A., Tsay C.et al. Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res. 50(24):1990;7950-7954.
43. Kanoe H., Nakayama T., Murakami H.et al. Amplification of the CDK4 gene in sarcomas: tumour specificity and relationship with the RB gene mutation. Anticancer Res. 18(4A):1998;2317-2322.
44. Momand J., Zambetti G.P., Olson D.C., George D.L., Levine A.J. The mdm2 oncogene product forms a complex with the p53 protein and inhibits p53 mediated transactivation. Cell. 69(7):1992;1237-1245.
45. Wang X., Wang S., Feng C. Detection of p53 and MDM2 gene expression in osteosarcoma with biotin-labelled in situ. Zhonghua Wai Ke Za Zhi. 35(3):1997;178-180.
46. Zhou X., Gao L., Zhe X. Alterations of MDM2 and p53 genes in bone tumours. Zhonghua Wai Ke Za Zhi. 26(5):1997;270-272.
47. Kato J., Matsushime H., Hiebert S.W., Ewen M.E., Sherr C.J. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7(3):1993;331-342.
48. Matsushime H., Quelle D.E., Shurtleff S.A., Shibuya M., Sherr C.J., Kato J.Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol. 14(3):1994;2066-2076.
49. Benassi M.S., Molendini L., Gamberi G., Ragazzini P., Sollazzo M.R., Merli M. Alteration of pRb/p16/cdk4 regulation in human osteosarcoma. Int J Cancer. 84(5):1999;489-493.
50. Park H.R., Park Y.K. Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone. J Korean Med Sci. 10(5):1995;360-367.
51. Wadayama B., Toguchida J., Yamaguchi T., Sasaki M.S., Yamamuro T. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br J Cancer. 68(6):1993;1134-1139.
52. Kawai A., Noguchi M., Beppu Y.et al. Nuclear immunoreaction of p53 protein in soft tissue sarcomas: a possible prognostic factor. Cancer. 73(10):1994;2499-2505.
53. Toguchida J., Yamaguchi T., Ritchie B., Beauchamp R.L., Dayton S.H., Herrera G.E. Mutation spectrum of the p53 gene in bone and soft tissue sarcoma. Cancer Res. 52(22):1992;6194-6199.
54. Ueda Y., Dockhorn-Dworniczack B., Blasius S., Mellin W., Wuisman P., Bocker W. Analysis of mutant p53 protein in osteosarcomas and other malignant and benign lesions of bone. J Cancer Res Clin Oncol. 119(3):1993;172-178.
55. Mousses S., McAuley L., Bell R.S., Kandel R., Andrulis I.L. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas. Mod Pathol. 9(1):1996;1-6.
56. Batsakis J.G., Solomon A.R., Rice D.H. The pathology of head and neck tumours. neoplasms of cartilage, bone and notochord Head Neck Surg. 3(6):1980;43-57.